eldecalcitol

Known as: (5z,7e)-2Beta-(3-Hydroxypropoxy)-9,10-Secocholesta-5,7,10(19)-Triene-1Alpha,3Beta,25-Triol, 1?,25-dihydroxy-2?-(3-hydroxypropoxy)cholecalciferol 
 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

20-epi-eldecalcitol

Broader (1)

Vitamin D
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats.
Postmenopausal women have high incidence of cardiovascular events as estrogen deficiency can cause endothelial dysfunction… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol
Eldecalcitol [1α,25-dihydroxy-2β-(3-hydroxypropyloxy)vitamin D3] is an analog of 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], bearing… (More)
Is this relevant?
Review
2013
Review
2013
Eldecalcitol and calcitriol stimulates ‘bone minimodeling,’ focal bone formation without prior bone resorption, in rat trabecular bone
Vitamin D is known as a potent stimulator of bone resorption. The active form of vitamin D3, calcitriol (1α,25-dihydroxyvitamin… (More)
Is this relevant?
2012
2012
Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
Eldecalcitol (ED-71), a 2β-hydroxypropyloxy derivative of 1α,25(OH)(2)D(3), inhibits bone resorption more potently than does… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Eldecalcitol (ED-71) is a new vitamin D₃ derivative recently approved for the treatment of osteoporosis in Japan. Previous… (More)
Is this relevant?
2011
2011
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
BACKGROUND Eldecalcitol is an analog of 1,25-dihydroxyvitamin D(3) that improves bone mineral density; however, the effect of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2011
2011
Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats.
To elucidate the histological events that follow administration of eldecalcitol, a second-generation of vitamin D analog… (More)
Is this relevant?
2011
2011
Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
The effects of an active vitamin D analog, eldecalcitol (ELD), on bone mineral density (BMD), bone geometry, and biomechanical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
The Vitamin D Analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) Vitamin D3 (Eldecalcitol) is a Potent Regulator of Calcium and Phosphate Metabolism
The vitamin D analog 1α,25-dihydroxy-2β-(3-hydroxypropyloxy)vitamin D3 (ED-71 or eldecalcitol) has been developed for treatment… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2010
2010
Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism
Eldecalcitol [ED-71, 2beta-(3-hydroxypropyloxy)-1,25-dihydroxyvitamin D3] increases lumbar and hip bone mineral density (BMD) in… (More)
Is this relevant?